PTGS2 and type 2 diabetes mellitus: Previous retrospective studies found that patients with diabetes type 2 and OA who were treated with metformin and cyclooxygenase-2 (COX-2) inhibitors experienced a decreased occurrence of joint replacement compared to patients who received only COX-2 inhibitors (Lu et al. 2018; Lai et al. 2022).